scholarly article | Q13442814 |
P50 | author | Marc Poirot | Q39184526 |
P2093 | author name string | Bowen WD | |
Faye JC | |||
Klaebe A | |||
Vilner BJ | |||
Daunes S | |||
Kedjouar B | |||
P2860 | cites work | Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression | Q24313077 |
Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1) | Q24336165 | ||
Purification, molecular cloning, and expression of the mammalian sigma1-binding site | Q24619317 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site | Q28568639 | ||
Physicochemical and genetic evidence for specific antiestrogen binding sites | Q37612930 | ||
Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity | Q40971042 | ||
Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C. | Q41297623 | ||
σ Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture | Q41345642 | ||
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis | Q41628454 | ||
Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists | Q42094838 | ||
Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the .sigma. receptor | Q45172168 | ||
A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypes | Q46220393 | ||
Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family? | Q47882555 | ||
Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil | Q48398727 | ||
Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site. | Q54268084 | ||
The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not. | Q54318013 | ||
Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. | Q55065614 | ||
Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability. | Q55481341 | ||
A proposal for the classification of sigma binding sites | Q67487993 | ||
Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme | Q68100142 | ||
Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions | Q69974413 | ||
A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role | Q70816651 | ||
Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture | Q72210279 | ||
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer | Q72240691 | ||
Potent interaction of histamine and polyamines at microsomal cytochrome P450, nuclei, and chromatin from rat hepatocytes | Q74530792 | ||
The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethamine.HCL, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study | Q77052315 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytotoxicity | Q246181 |
P304 | page(s) | 1927-1939 | |
P577 | publication date | 1999-12-01 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor | |
P478 | volume | 58 |
Q34068091 | Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands |
Q39839020 | Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism |
Q39715988 | Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle |
Q36427475 | Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds. |
Q44919464 | Molecular characterization of the microsomal tamoxifen binding site |
Q37000551 | Sigma receptors [σRs]: biology in normal and diseased states |
Q72995250 | Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS) |
Q36321725 | Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis |
Search more.